11 results
8-K/A
EX-99.1
CTCX
Carmell Corp - Ordinary Shares
14 Aug 23
Completion of Acquisition or Disposition of Assets
5:55pm
. The proprietary technology enables the manufacture of biologically active plastics from blood plasma for treating injuries to bone and soft tissue
425
CTCX
Carmell Corp - Ordinary Shares
6 Jul 23
Business combination disclosure
5:15pm
foot proven technology in a mix of reimbursed and ulcers, burn injuries self-pay markets
- Acquire commercial stage products and Potential … tibia fractures 2.64 1.3375% bridging Highly co-morbid population (e.g., 70% smokers) Composite* 70% most severe injuries* with significant 36% 0% soft
8-K
EX-99.1
qshwj0lrnd
6 Jul 23
Other Events
5:11pm
424B3
xqaj5
23 Jun 23
Prospectus supplement
4:47pm
- Prev
- 1
- Next